DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactCompany

Eris Lifesciences Limited — Investor Presentation

NSE 5 hrs ago·29 Jul 2026, 7:46 am

Eris Lifesciences

Eris Lifesciences Limited has announced the release of its investor presentation to the stock exchange. This document typically outlines the company's strategic roadmap, financial performance, and future growth plans for the upcoming period.

For investors, this update is a key opportunity to understand management's vision. It provides clarity on how the company plans to navigate the competitive pharmaceutical landscape and execute its growth strategies.

Investors should watch for details on revenue targets, new product launches, and operational efficiency. This information will be crucial for assessing the company's short-term and long-term prospects.